Governance bodies, commissioners and safety investigators note recurring patterns in perimenopause care: delays in recognition, attribution to psychosocial factors, fragmented pathways and documentation gaps. These contribute to avoidable harm, inefficiency and inequity.
Policy and Strategic Context
The Women’s Health Strategy for England (renewed 2026) identifies menopause and menstrual health as priorities, committing to redesigned community pathways, specialist hubs, improved training and integration of midlife health checks. NICE NG23 provides the core clinical framework for diagnosis and management.
System pressures include high consultation volumes, workforce challenges and digital tools that vary in sensitivity to hormonal symptoms. Inequalities in access persist for certain ethnic, socioeconomic and disabled groups.
Risk and Learning Themes
Safety investigations and claims data in women’s health frequently cite incomplete history-taking (especially menstrual patterns), lack of continuity, and failure to consider hormonal contributions alongside differentials. Accurate recognition supports better resource use, reduces inappropriate referrals and enables preventive opportunities in cardiovascular and bone health.
Improvement Opportunities
Structured documentation prompts, enhanced continuity models, better digital triage design, integrated pathways and strengthened professional education are highlighted across national sources. Midlife represents a key prevention window that governance structures should support rather than fragment.
Internal links: Patient Safety Investigations in Women’s Health Regulatory and Policy Landscape Continuity of Care Models
References
- NICE NG23.
- DHSC / NHS England Women’s Health Strategy (2022 and Renewed 2026).
- NIHR evidence syntheses.
- RCOG guidance.
- NHS resources and safety reports.
Mandatory disclaimer
This article is for general information and discussion only. It is not medical or legal advice, nor a substitute for professional advice. To contribute evidence, ideas, or corrections, please email womenshealthproject@outlook.com. Please do not share personal data when emailing. Individual cases cannot be reviewed.
This project does not offer any form of legal service and cannot assist with complaints, claims or individual advocacy. This platform is independent and not affiliated with any law firm, regulator, inquiry or clinical body.
© 2026 Women’s Health Inquiry Project (WHIP). This article includes original analysis of material from publicly available national sources. It may not be reproduced without permission.